Genotyping is the fastest way to identify antibiotic resistance.
The Power of Genomics
In a collaboration with Merck & Co., OpGen gained access to the Study for Monitoring Antimicrobial Resistance Trends (SMART) surveillance program, a curated library of more than 250,000 bacterial isolates from over 190 hospitals in over 50 countries. Using this access to one of the world’s largest surveillance studies of antimicrobial resistance, a universe of 20,000 known resistance genes was distilled to a comprehensive set with clinical utility and one suitable for a rapid diagnostic platform. Combined with the informatics of the Acuitas Lighthouse, resistance to a broad range of antibiotics can be now determined in hours instead of the days currently required for traditional methods.
The Acuitas AMR Gene Panel is a rapid diagnostic test for the detection of antimicrobial resistance. It is a highly multiplexed PCR test with an easy-to-use workflow and it reports results in less than 3 hours. Results can be uploaded to the Acuitas Lighthouse for the prediction of antibiotic resistance and for real-time surveillance of AMR threats. It is available for research use only and not for use in diagnostic procedures.
For Research Use Only. Not for use in diagnostic procedures.